Table 5.

Insurance coverage use by clinic setting

Medication	Total patients	African American	Non-Hispanic white	p
Enterprise-wide outpatients
AD/MCI patients	3,072	651	2,421
Covered	2,855 (92.9%)	596 (91.6%)	2,259 (93.3%)	0.13
Memory Disorders
AD/MCI patients	1,047	151	896
Covered	987 (94.3%)	140 (92.7%)	847 (94.5%)	0.34
Other Neurology
AD/MCI patients	783	112	671
Covered	737 (94.1%)	105 (93.8%)	632 (94.2%)	0.83
Primary Medicine
AD/MCI patients	311	149	162
Covered	283 (91.0%)	135 (90.6%)	148 (91.4%)	0.85
Geriatrics
AD/MCI patients	616	196	420
Covered	566 (91.9%)	177 (90.3%)	389 (92.6%)	0.34

Data presented as counts (percentages) with patient percentages taken out of racial subset total for each clinic setting; p values taken from conditional maximum likelihood exact test comparing African American proportions to non-Hispanic white proportions within each clinical setting. Covered patients had insurance coverage under either federally funded (Medicare A/B, Medicaid, Champus) or commercial programs. AD, Alzheimer’s disease; MCI, mild cognitive impairment.